Ryan Spencer, the Chief Executive Officer of Dynavax Technologies, has a robust background in the biopharmaceutical industry. Before becoming CEO in 2019, he held several key positions within Dynavax, including Interim Co-President and Senior Vice President of Commercial. His career began with roles such as Assistant Controller at QRS Corporation and a member of the audit practice at Ernst & Young.
His leadership has been pivotal in advancing Dynavax's commercial strategies and operational success.
Work History
Ryan Spencer's work history includes a variety of roles in the biopharmaceutical and financial sectors. Here is a detailed list of his previous positions:
- Dynavax Technologies - Chief Executive Officer (2019 - Present)
- Dynavax Technologies - Interim Co-President (2018 - 2019)
- Dynavax Technologies - Senior Vice President of Commercial (2017 - 2018)
- QRS Corporation - Assistant Controller (2000 - 2005)
- Ernst & Young - Member of the Audit Practice (1999 - 2000)
Education History
Ryan Spencer's educational journey laid a strong foundation for his successful career in the biopharmaceutical and financial sectors. He earned a Bachelor of Arts in Business Economics from the University of California, Santa Barbara. This academic background equipped him with the essential knowledge and skills in economics, finance, and business management, which have been pivotal in his various leadership roles at Dynavax Technologies and other companies. Spencer's education has undoubtedly played a crucial role in shaping his strategic vision and operational expertise.
